Skip to content

Bringing TB diagnosis closer to people using a new sputum and tongue swab based test

Evaluation of Near-Point-of-Care NAAT testing on swab samples for diagnosis of adult pulmonary Tuberculosis: A Hybrid Implementation-Effectiveness Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110243
Enrollment
6200
Registered
2026-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: Near-point-of-care NAAT testing on Huwel UniAMP using tongue swabs and sputum swabs: This study will evaluate the UniAMP Point-of-Care NAAT device, developed by Huwel Lifesciences, whic

Sponsors

Stop TB Partnership hosted by UNOPS (United Nations Office for Project Services) TB
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Main study : Testing of Presumptive TB in Healthcare Facilities Outpatients aged 18 years or above with any TB symptom (fever for 2 weeks or more, cough for 2 weeks or more, hemoptysis, weight loss, night sweats), willing to provide atleast one of tongue swab or sputum samples Sub-study 1: Household contacts investigation Adult household contacts of persons with TB initiated on treatment for TB in the study facilities during the study period, or in the three prior months prior to the start of the study Sub-study 2: Active case finding Adults screened in the community for TB by NTEP mobile XRay units, with symptoms of TB (fever for 2 weeks or more, cough for 2 weeks or more, hemoptysis, weight loss, night sweats) or risk factors (HIV, undernutrition, diabetes, smoking, alcohol use, past history of TB)

Exclusion criteria

Exclusion criteria: Participants with a current diagnosis of TB who are already receiving Anti Tubercular Therapy will be excluded.

Design outcomes

Primary

MeasureTime frame
NAAT Tested: Proportion of chest symptomatics tested by NAAT (swab-based NPoC NAAT and/or routine sputum CBNAAT or Truenat)Timepoint: within one week of participant identification

Secondary

MeasureTime frame
Sensitivity of swab-based NPoC NAAT for diagnosis of pulmonary TB with reference to sputum CBNAAT/Truenat and/or clinical decision to treatTimepoint: Within one month of participant identification;Participant/provider perceptions of acceptability of testTimepoint: Participant - Within one week of participant identification Provider - Interrim/end-line

Countries

India

Contacts

Public ContactDr Shruthee SG

Resource Group for Education and Advocacy for Community Health (REACH)

shruthee@reachindia.org.in9566024803

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026